Effect of dose adjustment on the safety and efficacy of afatinib for EGFR mutation-positive lung adenocarcinoma: post hoc analyses of the randomized LUX-Lung 3 and 6 trials - Concepedia

Concepedia

Publication | Closed Access

Effect of dose adjustment on the safety and efficacy of afatinib for EGFR mutation-positive lung adenocarcinoma: post hoc analyses of the randomized LUX-Lung 3 and 6 trials

182

Citations

20

References

2016

Year

James Chih‐Hsin Yang, Lecia V. Sequist, Caicun Zhou, Martin Schüler, Sarayut Lucien Geater, Tony Mok, Chengping Hu, Nobuyuki Yamamoto, J. Feng, Kenneth J. O’Byrne,

Annals of Oncology

References

	Year	Citations

Page 1